Publication

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT

de Hosson, L. D., van der Loo-van der Schaaf, A. M., Boellaard, R., van Snick, J. H., de Vries, E. G. E., Brouwers, A. H. & Walenkamp, A. M. E., Aug-2019, In : Clinical Nuclear Medicine. 44, 8, p. 612-619 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Interlesional Heterogeneity of Metastatic Neuroendocrine

    Final publisher's version, 580 KB, PDF document

    Request copy

DOI

Purpose Neuroendocrine tumors (NETs) can produce neuroendocrine amines resulting in symptoms. Selecting the most active amine-producing tumor lesions for local treatment might be beneficial for patients with metastatic small intestinal NET. Tumor burden correlates with catecholamine pathway activity. We analyzed interlesional heterogeneity with F-18-DOPA PET scans in patients with small intestinal NET and investigated if lesions with substantially higher F-18-DOPA uptake could be identified. Methods In this retrospective, observational study, the F-18-DOPA uptake was calculated by dividing SUVpeak of the lesion by the SUVmean of the background organ. The magnitude of heterogeneity between lesions within a patient was calculated by dividing the lesion with the highest by the one with the lowest F-18-DOPA uptake. Lesions with a higher F-18-DOPA uptake than the upper inner or outer fence (>1.5 or 3 times the interquartile range above the third quartile) were defined as lesions with mild or extreme high F-18-DOPA uptake, respectively, and presence of these was determined in patients with 10 lesions or more. Results F-18-DOPA was detected over 680 lesions in 38 patients, of which 35 were serotonin producing. F-18-DOPA uptake varied with a median of 8-fold up to 44-fold between lesions within a patient. In 12 of 20 evaluable patients, lesions with mild high F-18-DOPA uptake were found, and in 5, lesions with extreme high F-18-DOPA uptake. Conclusions F-18-DOPA-PET showed considerable heterogeneity in F-18-DOPA uptake between tumor lesions and identified lesions within patients with mild or extreme high F-18-DOPA uptake.

Original languageEnglish
Pages (from-to)612-619
Number of pages8
JournalClinical Nuclear Medicine
Volume44
Issue number8
Publication statusPublished - Aug-2019

    Keywords

  • F-18-DOPA PET scan, heterogeneity, neuroendocrine tumor, tracer uptake, LIVER-METASTASES, CARCINOID-TUMORS, GUIDELINES

ID: 95558181